MICHAEL JANTZ: Open Payments
NPI 1225077159 · GAINESVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$23,680 in 55 payments from 9 companies in 2025. Trend: 2023 $53,636 · 2024 $41,849 · 2025 $23,680
Consulting: $21,527Food & beverage: $1,152Travel & lodging: $1,002
| Company | Payments | Amount |
|---|---|---|
| GE HEALTHCARE | 8 | $22,619 |
| GlaxoSmithKline, LLC. | 15 | $320 |
| Pulmonx Corporation | 10 | $275 |
| AstraZeneca Pharmaceuticals LP | 11 | $184 |
| ANI Pharmaceuticals, Inc. | 4 | $132 |
| Insmed, Inc. | 3 | $72 |
| Amgen Inc. | 2 | $38 |
| Lilly USA, LLC | 1 | $22 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $18 |
Products named: OEC, NUCALA, CHARTIS CATHETER, PURIFIED CORTROPHIN GEL, TEZSPIRE, Arikayce, FASENRA, AIRSUPRA.
Industry payments across FL — which companies pay providers there.
